Treatment Response in Schizophrenia: Bridging Imaging and Postmortem Studies

Completed

Conditions studied: Schizophrenia

In brief

The overarching goal is to identify imaging markers that will predict treatment response, and to confirm or validate these biomarkers using anatomical studies of postmortem tissue. Early detection of drug response would yield specific treatment strategies that are tailored to the individual, thus improving both the quality of life of the patients and drastically reducing the costs associated with unsuccessful treatment strategies.

Key facts

Study ID

NCT00937716

Run by

University of Alabama at Birmingham

People needed

75

Starts

2008-10-01

Expected to finish

2021-06-30

Last updated by the study team

2021-07-26

Who can join

Age: 19 and older, up to 55. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Normal volunteers or schizophrenic patients between the age of 19 and 55.

You may not qualify if…

• Individuals with a diagnosable central nervous system illness.
• Major medical condition, active substance abuse or dependence, pregnancy, or history of head trauma.

Where it is running

• University of Alabama at Birmingham, Department of Psychiatry, SC 501 — Birmingham, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.